BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 3487514)

  • 1. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemotactic inhibitory factor in the minimal change nephrotic syndrome.
    Lin CY; Su SN
    Int J Pediatr Nephrol; 1986; 7(4):191-6. PubMed ID: 3818178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte nitroblue tetrazolium test and chemotaxis in children with nephrotic syndrome and nephritis.
    Lin CY; Young WN
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):52-60. PubMed ID: 3595264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenetical study in patients with chronic glomerulonephritis.
    Komori K; Nose Y; Inouye H; Tsuji K; Nomoto Y; Tomino Y; Sakai H; Iwagaki H; Itoh H; Hasegawa O
    Tokai J Exp Clin Med; 1983 May; 8(2):135-48. PubMed ID: 6419404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary nephrotic syndrome in children and histopathologic study.
    Kirdpon S; Vuttivirojana A; Kovitangkoon K; Poolsawat SS
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():26-31. PubMed ID: 2732642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis.
    Hui A; Poucell S; Thorner P; Rance CP; Baumal R
    Int J Pediatr Nephrol; 1984 Mar; 5(1):5-10. PubMed ID: 6370883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological mechanisms in glomerulonephritis. A short review and analysis of peripheral mononuclear cell subsets in IgA nephropathy and membranous glomerulonephritis.
    Pettersson E; von Willebrand E; Honkanen E
    Scand J Urol Nephrol Suppl; 1985; 90():29-34. PubMed ID: 3879379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood nephrotic syndrome and heavy proteinuria in Taiwan. A retrospective clinicopathologic study.
    Chen WP; Lin CY; Hsu HC; Chiang H
    Child Nephrol Urol; 1988-1989; 9(1-2):57-64. PubMed ID: 3251622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy.
    Suga T; Endoh M; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1984 Jun; 9(2):95-101. PubMed ID: 6398930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
    Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.
    Herrod HG; Stapleton FB; Trouy RL; Roy S
    Clin Exp Immunol; 1983 Jun; 52(3):581-5. PubMed ID: 6603300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
    Ozaki T
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults.
    Yokoyama H; Kida H; Abe T; Koshino Y; Yoshimura M; Hattori N
    Clin Exp Immunol; 1987 Oct; 70(1):110-5. PubMed ID: 3500811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA; Halawani M; Mokhtar G; Jalalah SM; Anshasi W
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.
    Dall'Aglio P; Chizzolini C; Brigati C
    Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-T cell antibodies in primary glomerulonephritis.
    Nakabayashi K; Arimura Y; Yoshida M; Nagasawa T
    Clin Nephrol; 1985 Feb; 23(2):74-80. PubMed ID: 3872758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
    Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
    Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.